U.S. FDA Selects ComplianceQuest QRC System to Modernize Enterprise QMS

U.S. FDA Selects ComplianceQuest QRC System to Modernize Enterprise QMS

U.S. FDA Selects ComplianceQuest QRC System to Modernize Enterprise QMS

Audit-Ready Always: How Quality Leaders Prepare for Unannounced and Remote Audits
Tania Ghosh
Tania Ghosh | November 5th, 2026

Audit-Ready Always: How Quality Leaders Prepare for Unannounced and Remote Audits

Quick Summary (TL;DR)

Quality leaders stay ready for unannounced and remote audits by making audit readiness continuous, not by preparing harder. The reason is regulatory. FDA has expanded unannounced inspections to foreign sites and formalized remote regulatory assessments as a standing oversight tool.

For medical device makers, the Quality Management System Regulation (QMSR) has also opened internal audit and management review records to inspection.

Continuous readiness means running operations where every record is captured right at the point of work. Every deviation links to its investigation and corrective and preventive action (CAPA), and every batch or device history record can be pulled up in minutes.

It grows out of a connected quality management system (QMS) and pays back in faster release, lighter QA review, and lower cost of quality.

What If an FDA Investigator Walked In Tomorrow?

If an FDA investigator walked into your lobby tomorrow morning, unannounced, how long would it take your team to show how last month's critical deviation was closed?

Be honest. If the answer is "give us a few hours," you are in good company. You are also running out of time to stay there.

Through August of fiscal year 2026, 87% of the inspections run by FDA's India office were unannounced, up from 47% a year earlier. In China, the share jumped from 19% to 61%. Similarly, the percentage of unannounced audits is going up globally.

So, picture that Tuesday morning.

QA starts a dizzying hunt across three systems. Two people disagree on which SOP version was live last quarter. Leadership has no single view of open deviations.

The product may be fine.

The proof is what's missing.

What Has Changed in How Regulators Audit Regulated Manufacturers?

Since mid-2025, three shifts have rewritten the rules of inspection. Unannounced visits now reach foreign sites, remote assessments are formalized, and device makers' internal records are open to review.

Unannounced Inspections Now Reach Every Site

Domestic FDA inspections were already largely unannounced. Foreign sites are now held to the same standard, which matters if your network includes overseas plants or suppliers.
In Europe, MDR Annex IX 3.4 requires notified bodies to run unannounced audits at least once every five years.

Remote Assessments Are Here to Stay

FDA finalized its remote regulatory assessment (RRA) guidance in June 2025. Remote audits test one thing: whether your evidence exists in a form you can send. Your records can now be reviewed before a visit, or sometimes without one.

Internal Records Are No Longer Off-Limits

For medical device manufacturers, the QMSR changed the deal on February 2, 2026. FDA's own QMSR FAQ confirms it can now review internal audit reports, supplier audit reports, and management review records that were previously shielded. The audits you ran for your own eyes are now part of the story an investigator can read.

Why Does Traditional Audit Preparation Fail Modern Quality Teams?

Traditional audit preparation fails because it depends on notice.

Most quality teams know the drill. An audit is announced, a war room forms, and two weeks vanish into rebuilding evidence that should already exist.

1. Fragmented Systems

  • Deviations, CAPAs, training, and batch data live in different places.
  • When an inspector asks how a deviation was closed, someone has to stitch the story together while the clock runs.

2. Reactive Documentation

  • Records completed after the work leave late entries and missing signatures.
  • And the investigator, not your team, finds them first.

3. Limited Visibility

Without a live view of open deviations and overdue CAPAs, leaders learn how ready they are at the worst possible moment: when an audit tests them.

4. High QA Review Burden

QA teams get bludgeoned by line-by-line review of every record. Reviewers become the bottleneck between production and release, and your best people end up confirming entries that were never in doubt.

What Is Continuous Audit Readiness? Why Does It Even Matter?

Continuous audit readiness means every record an inspector could ask for is complete, current, traceable, and retrievable at any moment.

That is only possible when records are created right the first time, not assembled for the audit.

In practice, it rests on four elements:

  • End-to-end traceability from material to release
  • Real-time visibility into batch and quality events
  • Connected deviations, complaints, CAPA, and change control
  • Audit-ready records you can share in minutes, on-site or remotely

From Audit Preparation to Continuous Readiness

Dimension Reactive Audit PreparationContinuous Readiness
Evidence Gathered manually before the audit Captured at the point of work
Data Fragmented across systems One connected source of truth
Visibility Known when the audit tests it Visible on a live dashboard
QA Review Line by line By exception
Remote Requests Manual collation against a deadline Controlled access in minutes

How Does Continuous Readiness Improve Operations Beyond the Audit?

Continuous readiness pays off well beyond the audit. That is the part that rarely makes it into audit-prep meetings. If you are measured on throughput and cost, readiness is not additional work. It is a by-product of running the operation well.

  • Fewer Deviations - Enforced steps and in-process checks catch errors during execution, not days later at review.
  • Faster Batch Review and Release - Review by exception points QA only to flagged items.
  • Stronger Audit Outcomes - Complete, linked records shorten response times and reduce observations, internal audits included.
  • Lower Cost of Quality - Every hour spent chasing documents before an audit is cost of quality. Continuous readiness hands most of those hours back.

What Capabilities Enable Continuous Audit Readiness?

Ever wondered, what distinguishes an operation that is always ready from one that scrambles? The five capabilities mentioned below –

  • Guided, enforced workflows that keep operators on the approved process and SOP version
  • Real-time data capture with audit trails and Part 11 e-signatures supporting ALCOA+
  • Closed-loop quality processes linking each deviation to its investigation, CAPA, and change
  • Records ready by design, version-controlled in one repository
  • Connected traceability across MES, LIMS, ERP, PLM, and supplier quality data

The next-gen AI-powered EQMS by ComplianceQuest brings all these capabilities together on a single platform. It helps organizations stay inspection-ready every day instead of rebuilding it before every audit.

Why Is Audit Readiness Now a Measure of Operational Maturity?

Whether you make medical devices, pharmaceuticals, or high-tech products, regulators now expect the same thing:

Complete, traceable data at any moment. Audit readiness is no longer just a compliance task sitting beside operations. It reflects how impeccably those operations run.

Digital quality makes that visible, turning regulatory compliance into something you can demonstrate on demand.

So come back to that Tuesday morning. The investigator is in the lobby. This time, the deviation record, its investigation, and its closed CAPA are on screen in minutes.

No war room! Zero scramble. Just an operation that was ready because it is always run that way.

Audit Readiness for Quality Leaders

Key Takeaways

  • Unannounced inspections, formalized remote assessments, and QMSR record access make audit readiness a daily requirement.
  • Continuous readiness replaces evidence reconstruction with records created at the point of work.
  • The payoff is operational: fewer deviations, faster release, and lower cost of quality.

Frequently Asked Questions

  • Maintain current procedures, controlled records, training evidence, and documented quality investigations. Monitor unresolved CAPAs and conduct mock inspections that test evidence retrieval without advance preparation.

  • Depending on the assessment scope, FDA may request production, quality, training, investigation, and corrective action records. Manufacturers should establish secure retrieval and sharing procedures and verify that records are complete and traceable.

    • Effective February 2, 2026, QMSR permits FDA review of internal audit, supplier audit, and management review reports previously covered by an inspection exemption.
    • Manufacturers should maintain these records with the same attention to accuracy, completeness, and oversight as other QMS evidence.

Request a Free Demo

Learn about all features of our Product, Quality, Safety, and Supplier suites. Please fill the form below to access our comprehensive Demo Video.

Please confirm your details

Graphic
×
spinner
Consult Now

Comments